KYMR vs PEP · rev $99.4M vs P/E 22, rev $43.62B
Kymera Therapeutics Inc (KYMR) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
KYMR currently screens at market cap $7.39B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the KYMR and PEP stock pages for the full models.
Not investment advice.